Suppr超能文献

miR-20a过表达对人T细胞白血病细胞系细胞增殖的影响

The Effect of Over-Expression of miR-20a on Cell Proliferation of Human T Cell Leukemia Cell Line.

作者信息

M Razavi Hashemi, R Vahabpour, N Ranji, Mh Sanati, M Mapar, Sm Sadat

出版信息

Clin Lab. 2018 Oct 1;64(10):1641-1647. doi: 10.7754/Clin.Lab.2018.180406.

Abstract

BACKGROUND

Acute T Cell Leukemia (ALL) is an aggressive and prevalent human malignancy. Chemotherapy is the most frequent therapeutic strategy; however, cytotoxicity and recurrence of cancer are the main concerns. The discovery of microRNA (miRNA) drew the attention of scientists who were working on targeted cancer therapy to use the potential of gene regulation by using this small RNAs.

METHODS

miRanda, TargetScan, miRDB databases, and miRWalk software were applied to find probable miRNAs targeting 3'UTR of JAK1, STAT3, SOCS6, AKT1, APAF, BID, and Caspase9 mRNA. A lentiviral vector encoding miR-20a was used for overexpression of the miR-20a in C8166 cell lines to investigate the expression level of genes that are associated with the JAK/STAT signaling pathway and apoptosis using quantitative RTPCR. The effects of miR-20a overexpression also were examined on cell-cycle progression by flow cytometry.

RESULTS

qRT-PCR results indicated that overexpression of miR-20a in C8166 cells resulted in significantly elevated expression of BID and Caspase9 (p-value < 0.01). Overexpression of miR-20a in C8166 cells led to cell cycle arrest at the G0/G1 phase.

CONCLUSIONS

The results suggested miR-20a may act as a tumor suppressor in CD4+ T cells and also has a potential therapeutic in these kinds of cancers.

摘要

背景

急性T细胞白血病(ALL)是一种侵袭性且常见的人类恶性肿瘤。化疗是最常用的治疗策略;然而,细胞毒性和癌症复发是主要问题。微小RNA(miRNA)的发现引起了致力于靶向癌症治疗的科学家的关注,他们希望利用这种小RNA的基因调控潜力。

方法

应用miRanda、TargetScan、miRDB数据库和miRWalk软件,寻找可能靶向JAK1、STAT3、SOCS6、AKT1、APAF、BID和Caspase9 mRNA 3'UTR的miRNA。使用编码miR-20a的慢病毒载体在C8166细胞系中过表达miR-20a,通过定量RT-PCR研究与JAK/STAT信号通路和细胞凋亡相关的基因的表达水平。还通过流式细胞术检测miR-20a过表达对细胞周期进程的影响。

结果

qRT-PCR结果表明,C8166细胞中miR-20a的过表达导致BID和Caspase9的表达显著升高(p值<0.01)。C8166细胞中miR-20a的过表达导致细胞周期停滞在G0/G1期。

结论

结果表明miR-20a可能在CD4+T细胞中作为肿瘤抑制因子发挥作用,并且在这类癌症中也具有潜在的治疗作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验